Masakazu Tanaka Selected Research

Infections

1/2020	Expression of TSLC1 in patients with HAM/TSP.
1/2019	Conflicting effects of poly(ADP-ribose) polymerase inhibitor on cell-mediated and virion-mediated HTLV-1 infection.
2/2010	Neuraminidase enhances the initial steps of human T-cell leukemia virus type 1 replication.
5/2008	Reduction of human T-cell leukemia virus type-1 infection in mice lacking nuclear factor-kappaB-inducing kinase.
7/2002	Cell-free human T-cell leukemia virus type 1 binds to, and efficiently enters mouse cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masakazu Tanaka Research Topics

Disease

6	Neoplasms (Cancer) 12/2023 - 05/2008
5	Infections 01/2020 - 07/2002
5	Hypertension (High Blood Pressure) 03/2006 - 09/2004
4	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 01/2013
4	Stroke (Strokes) 03/2006 - 11/2004
4	Fibrosis (Cirrhosis) 01/2005 - 05/2002
3	Inflammation (Inflammations) 03/2023 - 05/2003
3	Cholangiocarcinoma 03/2023 - 12/2013
3	T-Cell Leukemia (Leukemia, T Cell) 01/2021 - 05/2008
3	Vascular Remodeling 01/2005 - 09/2004
2	Aneuploidy (Aneuploid) 12/2023 - 03/2022
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 01/2011
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 08/2016
2	Prostatic Neoplasms (Prostate Cancer) 12/2017 - 11/2014
2	Atherosclerosis 01/2011 - 05/2002
2	Hypercholesterolemia 11/2006 - 05/2002
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2005 - 11/2004
1	Seizures (Absence Seizure) 01/2023
1	Conversion Disorder (Astasia Abasia) 01/2023
1	Hypertriglyceridemia 01/2021
1	Tropical Spastic Paraparesis (Tropical Spastic Paraplegia) 01/2020
1	Tumor Virus Infections (Shope Fibroma) 05/2019
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Hemorrhage 01/2018
1	Disseminated Intravascular Coagulation 01/2018
1	Carcinoma (Carcinomatosis) 12/2017
1	Alzheimer Disease (Alzheimer's Disease) 08/2016
1	Central Nervous System Diseases (CNS Diseases) 08/2016
1	Weight Gain 04/2016
1	Chromosomal Instability (Chromosome Stability) 02/2016
1	Acute Erythroblastic Leukemia (Erythroleukemia) 01/2016
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 11/2014
1	Ataxia Telangiectasia (Louis Bar Syndrome) 02/2012
1	Dyslipidemias (Dyslipidemia) 01/2011

Drug/Important Bio-Agent (IBA)

6	EnzymesIBA 03/2023 - 05/2003
4	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 07/2002
4	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2023 - 01/2019
4	Biomarkers (Surrogate Marker)IBA 12/2017 - 06/2014
4	Polysaccharides (Glycans)IBA 12/2017 - 11/2014
4	Proteins (Proteins, Gene)FDA Link 12/2013 - 08/2009
4	Nitric Oxide Synthase (NO Synthase)IBA 01/2005 - 05/2002
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 04/2005 - 09/2004
3	NADPH Oxidases (NAD(P)H oxidase)IBA 04/2005 - 05/2002
2	3-aminobenzamideIBA 12/2023 - 03/2022
2	Poly Adenosine Diphosphate RiboseIBA 02/2016 - 12/2013
2	AntioxidantsIBA 01/2011 - 05/2002
2	Superoxide Dismutase-1IBA 11/2006 - 11/2004
2	Probucol (Lorelco)FDA Link 11/2006 - 05/2002
2	Amlodipine (Norvasc)FDA LinkGeneric 03/2006 - 11/2004
2	Enalapril FDA LinkGeneric 03/2006 - 09/2004
2	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2005 - 01/2005
2	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 01/2005 - 05/2002
2	Angiotensin IIIBA 01/2005 - 09/2004
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2005 - 09/2004
2	Superoxides (Superoxide)IBA 11/2004 - 05/2002
2	Myosin Heavy Chains (Myosin Heavy Chain)IBA 09/2004 - 05/2002
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2023
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2023
1	1- (4- dimethylaminomethylphenyl)- 8,9- dihydro- 7H- 2,7,9a- benzo(cd)azulen- 6- oneIBA 12/2023
1	CarcinogensIBA 03/2023
1	AntibodiesIBA 01/2023
1	Cholinergic ReceptorsIBA 01/2023
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	MetalsIBA 01/2021
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA 01/2020
1	Small Interfering RNA (siRNA)IBA 01/2020
1	Cell-Penetrating PeptidesIBA 01/2020
1	MutagensIBA 05/2019
1	olaparibIBA 01/2019
1	Alcohol Dehydrogenase (Alcohol Dehydrogenase (NAD+))IBA 01/2019
1	EdaravoneIBA 09/2018
1	Liposomes (Liposome)IBA 09/2018
1	Hemostatics (Antihemorrhagics)IBA 01/2018
1	Hormones (Hormone)IBA 01/2018
1	ThrombomodulinIBA 01/2018
1	Dacarbazine (DIC)FDA LinkGeneric 01/2018
1	Immunoglobulins (Immunoglobulin)IBA 12/2017
1	BilirubinIBA 01/2016
1	Abiraterone AcetateIBA 11/2014
1	cabazitaxel FDA Link 11/2014
1	Taxoids (Taxanes)IBA 11/2014
1	AndrogensIBA 11/2014
1	SugarsIBA 06/2014
1	Blood Proteins (Serum Proteins)IBA 06/2014
1	Glutathione (Reduced Glutathione)IBA 12/2013
1	TransferasesIBA 12/2013
1	8-hydroxyguanineIBA 12/2013
1	X-ray Repair Cross Complementing Protein 1IBA 12/2013
1	Indicators and Reagents (Reagents)IBA 01/2013
1	Methylnitronitrosoguanidine (MNNG)IBA 02/2012
1	Eicosapentaenoic AcidIBA 01/2011
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2011
1	Neuraminidase (Sialidase)IBA 02/2010

Therapy/Procedure

4	Therapeutics 03/2022 - 01/2011
1	Stents 01/2021
1	Percutaneous Coronary Intervention 01/2021
1	Blood Transfusion (Blood Transfusions) 01/2018
1	Castration 11/2014